These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11563240)

  • 21. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.
    Carr A; Samaras K; Burton S; Law M; Freund J; Chisholm DJ; Cooper DA
    AIDS; 1998 May; 12(7):F51-8. PubMed ID: 9619798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical review 153: Lipodystrophy in human immunodeficiency virus-infected patients.
    Chen D; Misra A; Garg A
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4845-56. PubMed ID: 12414837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: correlation between dyslipidaemia and steroid hormone alterations.
    Christeff N; Melchior JC; de Truchis P; Perronne C; Nunez EA; Gougeon ML
    AIDS; 1999 Nov; 13(16):2251-60. PubMed ID: 10563710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-associated wasting in the HAART era: guidelines for assessment, diagnosis, and treatment.
    Polsky B; Kotler D; Steinhart C
    AIDS Patient Care STDS; 2001 Aug; 15(8):411-23. PubMed ID: 11522215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and management of body morphology changes and lipid abnormalities associated with HIV Infection and its therapies.
    Wohl DA
    Top HIV Med; 2004; 12(3):89-93. PubMed ID: 15310940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complementary and alternative therapies to manage HIV-related symptoms.
    Swanson B; Keithley JK; Zeller JM; Cronin-Stubbs D
    J Assoc Nurses AIDS Care; 2000; 11(5):40-56; quiz 57-60. PubMed ID: 11022331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nutrition and HIV infection: review of weight loss and wasting in the era of highly active antiretroviral therapy from the nutrition for healthy living cohort.
    Mangili A; Murman DH; Zampini AM; Wanke CA
    Clin Infect Dis; 2006 Mar; 42(6):836-42. PubMed ID: 16477562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nutritional status of patients with HIV-AIDS infection].
    López-Herce JA
    An Med Interna; 1998 Dec; 15(12):623-6. PubMed ID: 9972594
    [No Abstract]   [Full Text] [Related]  

  • 29. Current antiretroviral therapy and its impact on human immunodeficiency virus-related wasting.
    Sherer R
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):92-7. PubMed ID: 9625390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The metabolic puzzle during the evolution of HIV infection.
    Salas-Salvadó J; García-Lorda P
    Clin Nutr; 2001 Oct; 20(5):379-91. PubMed ID: 11534932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiretroviral-related nutritional problems: closing the science and practice gap.
    Keithley JK; Fields-Gardner C
    J Assoc Nurses AIDS Care; 2001; 12 Suppl():85-7. PubMed ID: 11563243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of hunger and appetite and their relationship to food intake in persons with HIV infection.
    Lennie TA; Neidig JL; Stein KF; Smith BA
    J Assoc Nurses AIDS Care; 2001; 12(3):66-74. PubMed ID: 11387806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Metabolic disorders associated with HIV and antiretroviral therapy].
    Roca B
    An Med Interna; 2003 Nov; 20(11):585-93. PubMed ID: 14624657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipodystrophy syndrome in children infected with human immunodeficiency virus.
    Wedekind CA; Pugatch D
    Pharmacotherapy; 2001 Jul; 21(7):861-6. PubMed ID: 11444583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating alternative treatments for HIV infection.
    Freeman EM; MacIntyre RC
    Nurs Clin North Am; 1999 Mar; 34(1):147-62. PubMed ID: 9922284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is gold always present in a "gold standard"?
    Keithley JK
    JPEN J Parenter Enteral Nutr; 2002; 26(4):256. PubMed ID: 12090692
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevalence and predictors of HIV-associated weight loss in the era of highly active antiretroviral therapy.
    Batterham MJ; Garsia R; Greenop P
    Int J STD AIDS; 2002 Nov; 13(11):744-7. PubMed ID: 12437893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wasting and body changes: what do we know so far?
    Gomez E
    Newsline People AIDS Coalit N Y; 1998 Sep; ():34-6. PubMed ID: 11367489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic and morphologic complications of HIV infection.
    Eid AJ; Orenstein R
    J Med Liban; 2006; 54(2):97-105. PubMed ID: 17087001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nutrition and the HIV-associated lipodystrophy syndrome.
    Loonam CR; Mullen A
    Nutr Res Rev; 2012 Dec; 25(2):267-87. PubMed ID: 23174511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.